83 studies found for:    Open Studies | "Bone Diseases, Infectious"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Bone Diseases, Infectious"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
Condition: Spondylitis, Ankylosing
Intervention: Biological: Etanercept
2 Recruiting Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Conditions: Axial Spondyloarthrithis;   Ankylosing Spondylitis
Interventions: Biological: Certolizumab Pegol;   Other: Placebo
3 Not yet recruiting AL-2 MP-1 (Polyimide) Acetabular Liner
Conditions: Osteoarthritis;   Avascular Necrosis;   Rheumatoid Arthritis;   Congenital Dysplasia of the Hip;   Ankylosing Spondylitis;   Post-traumatic; Arthrosis;   Injury of Hip
Intervention: Device: MP-1 Polymer on Ceramic Articulation system
4 Recruiting Biomarkers Identification of Anti-TNF α Agent's Efficacy in Ankylosing Spondylitis Patients
Condition: Ankylosing Spondylitis
Intervention: Drug: Adalimumab
5 Recruiting Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study
Condition: Ankylosing Spondylitis
Interventions: Biological: Adalimumab;   Biological: Etanercept
6 Recruiting A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Axial Spondyloarthritis;   Plaque Psoriasis
Intervention: Drug: Etanercept
7 Recruiting The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis
Condition: Tuberculosis, Spinal
Interventions: Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide
8 Not yet recruiting Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
Condition: Ankylosing Spondylitis
Interventions: Drug: NSAIDs;   Drug: anti-TNF
9 Not yet recruiting Phenomics in Autoimmune and Inflammatory Diseases
Conditions: Healthy Volunteer;   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus/Antiphospholipid Syndrome;   FMF;   Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome;   Vasculitis;   Uveitis;   Myositis;   Crohn's Disease;   Ulcerative Rectocolitis;   Type 1 Diabetes;   Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions: Other: 1: AID groups;   Other: 2: Control groups
10 Recruiting UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository
Conditions: Diabetic Foot Ulcers;   Osteomyelitis
Intervention: Other: DFU
11 Recruiting Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: TNF alpha;   Drug: NSAIDs and sulfasalazine
12 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
13 Not yet recruiting A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Naive Participants With Active Radiographic Axial Spondyloarthritis
Condition: Axial Spondyloarthritis
Interventions: Drug: Placebo;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg;   Drug: Golimumab 50 mg
14 Recruiting An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
Condition: Nonradiographic Axial Spondylitis, Ankylosing
Interventions: Drug: Group 1: Placebo;   Drug: Group 2: Ustekinumab 45 mg;   Drug: Group 3: Ustekinumab 90 mg
15 Not yet recruiting The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
Conditions: Inflammatory Bowel Diseases;   Ankylosing Spondylitis
Interventions: Procedure: Pinch biopsies;   Procedure: Flexible sigmoidoscopy
16 Recruiting Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction
Condition: Alveolar Osteitis
Interventions: Drug: DC071;   Drug: Placebo
17 Recruiting COMorbidities and EDucation in SPondyloArthritis Study
Condition: Axial Spondyloarthritis
Interventions: Behavioral: self-assessment/self-management;   Behavioral: Comorbidities (detection/prevention)
18 Recruiting Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein
Condition: Spondyloarthritis
Interventions: Drug: etanercept;   Drug: etanercept (half dose);   Drug: placebo
19 Recruiting Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Infliximab (BCD-055);   Drug: Infliximab (Remicade)
20 Recruiting The Effect of Exercise on Disease Activity and Cardiovascular Risk for Patients With Axial SpondyloArthritis
Condition: Axial Spondyloarthritis
Intervention: Behavioral: Exercise

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years